Target intelligence / Profile preview

DNA polymerase; RNA polymerase (null)

Target
null
Molecular classification
Enzyme, Polymerase
01

Overview

DNA polymerase is an enzyme family responsible for synthesizing new DNA strands during DNA replication, ensuring the faithful duplication of the genome before cell division. DNA polymerases add deoxyribonucleotides to a growing DNA chain, using a template strand and a primer, and possess proofreading activity to correct errors[2][5]. RNA polymerase is a multi-subunit enzyme complex that synthesizes RNA from a DNA template in the process of transcription, a key step in gene expression. Unlike DNA polymerase, RNA polymerase does not require a primer and produces RNA (not DNA), using ribonucleotides and unwinding DNA transiently as it copies the genetic code[2][3][4][7][8][9]. In eukaryotes, three main forms exist (Pol I, Pol II, Pol III) with distinct gene targets[4][7]. Note: The combined term "DNA polymerase and RNA polymerase" is not considered a canonical target and should be split into two separate targets for accurate mapping and structured information[2][5][7]. Each has distinct drug interactions, clinical utilities, and molecular characteristics.

Other names
DNA polymerasedeoxyribonucleic acid polymeraseRNA polymeraseribonucleic acid polymeraseDNAPRNAP
02

Mechanism of action

DNA polymerase inhibitors typically act as chain terminators (nucleoside analogues) or via active site inhibition. RNA polymerase inhibitors may block initiation, elongation, or directly bind the enzyme to halt transcription.

03

Biological functions

DNA replicationProofreadingDNA repairTranscriptionGene expressionRNA synthesis
04

Disease associations

CancerInfection (as viral and bacterial polymerases are drug targets)Genetic disease
05

Safety considerations

DNA polymerase inhibitors can be toxic to rapidly dividing healthy cells, causing myelosuppression, mucositis.RNA polymerase inhibitors may risk hepatotoxicity, hypersensitivity, or disrupt normal gene expression if not specific to target pathogens.
06

Interacting drugs

Nucleoside analogues (e.g., cytarabine, acyclovir, zidovudine)

6 more in the full profile.

07

Biomarkers

Increased DNA polymerase activity can be a marker of cell proliferation.Mutations or overexpression of certain RNA polymerase subunits (e.g., POLR genes in cancer or infection).

Beyond the preview

Go deeper on DNA polymerase; RNA polymerase (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase; RNA polymerase (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call